| An update on sphingosine-1-phosphate receptor 1 modulators A Marciniak, SM Camp, JGN Garcia, R Polt Bioorganic & medicinal chemistry letters 28 (23-24), 3585-3591, 2018 | 33 | 2018 |
| In silico Docking Studies of Fingolimod and S1P1 Agonists A Marciniak, SM Camp, JGN Garcia, R Polt Frontiers in Pharmacology 11, 247, 2020 | 10 | 2020 |
| Sphingosine-1-phosphate receptor-independent lung endothelial cell barrier disruption induced by FTY720 regioisomers SM Camp, A Marciniak, ET Chiang, AN Garcia, R Bittman, R Polt, ... Pulmonary circulation 10 (1), 10.1177 _2045894020905521, 2020 | 7 | 2020 |
| Development of Immune Modulators Targeting Autoimmune Disorders and Pulmonary Injury: Design, Synthesis, and Biological Evaluation of Sphingolipid-Derived Sphingosine-1 … A Marciniak The University of Arizona, 2022 | | 2022 |
| Lessons in Stereochemistry: Resolution, Synthesis, and Characterization of Chiral Compounds KA Scott, A Marciniak, WG Benson, R Polt Journal of Chemical Education 97 (12), 4339-4344, 2020 | | 2020 |
| SARu2013based meta drug strategy: Design and total synthesis of novel S1P1 modulators for autoimmune disease and ALI/ARDS treatment C Apostol, N Christie, A Katz, A Marciniak, S Glaser, R Polt, J Garcia, ... American Chemical Society SciMeetings 1 (2), 2020 | | 2020 |
| Lessons in stereochemistry: Resolution, synthesis, and characterization of biologically relevant amino acids A Marciniak, K Scott, W Benson, R Polt ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
| Selecting a method for economic evaluation of simultaneous risk reduction: The example of selective estrogen receptor modulators (SERMs) R Tretiak, A Marciniak, C Petrie, C Gable, M Botteman OSTEOPOROSIS INTERNATIONAL 11, S8-S8, 2000 | | 2000 |
